No Carolina / NY / Florida
Ph: 561.316.3330

Northwell Health to Advance Health Care Innovation Amid COVID-19 Pandemic at Constellation Forum

Summation

  • Geoffrey Ling, Founding Director of DARPA Biological Technologies Office and Chief Executive Officer of On Demand Pharmaceuticals and, Kevin Tracey, President and CEO of the Feinstein Institutes for Medical Research will come together to share insights, best practices and the challenges facing health care amid this unprecedented time in order to collectively advance health care innovation.
  • This year's Forum will focus on the coronavirus disease 2019 (COVID-19) pandemic as it has highlighted the increased demands on health care innovation and on those who bring it to life.
  • “Northwell Health has been at the center of the COVID-19 pandemic, treating more patients than any other health system globally and is working vigorously to overcome its challenges,” said Mr.

Northwell Health will host its third annual Constellation Forum virtually on Thursday, August 6 from 11 a.m. to 2 p.m. This year’s Forum will focus on the coronavirus disease 2019 (COVID-19) pandemic as it has highlighted the increased demands on health care innovation and on those who bring it to life. All are welcome to register for the free event here.

The Constellation Forum will explore what can be learned from efforts today in order to prepare whatever comes next. Northwell’s President and CEO, Michael Dowling, and an influential group of leaders, including Eric Schmidt, Former CEO & Chairman of Google and Co-Founder of Schmidt Futures; Joaquin Duato, Vice Chairman of the Executive Committee from Johnson & Johnson; Kevin Lobo, Chief Executive Officer of Stryker; Ann Lamont, Co-Founder & Managing Partner at Oak HC/FT; Cori Bargmann, Head of Science at the Chan Zuckerberg Initiative; Stanley Bergman, Chairman of the Board & CEO of Henry Schein; Geoffrey Ling, Founding Director of DARPA Biological Technologies Office and Chief Executive Officer of On Demand Pharmaceuticals and, Kevin Tracey, President and CEO of the Feinstein Institutes for Medical Research will come together to share insights, best practices and the challenges facing health care amid this unprecedented time in order to collectively advance health care innovation.

To recognize Governor Andrew Cuomo for his leadership during this crisis, he will be presented with an honorary degree and provide remarks.

“Northwell Health has been at the center of the COVID-19 pandemic, treating more patients than any other health system globally and is working vigorously to overcome its challenges,” said Mr. Dowling. “This Forum gives us the chance to further enhance collaboration and accelerate changes within health care to benefit not only our patients but also patients around the world.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

New Inflammatory Bowel Disease Center Opens at Northwell Health

The new Inflammatory Bowel Disease Center, located at 125 Community Drive in Manhasset, has 13 exam rooms, two procedural rooms and six infusion bays. Since it started operations, people have travelled from all over the country – and as far away as Alaska – to receive high-quality care.

Cold Spring Harbor Laboratory and Northwell Health Extend Strategic Affiliation

“The alliance between Cold Spring Harbor Laboratory (CSHL) and Northwell Health brings transformative bioscience research into the clinic,” says CSHL President & CEO Bruce Stillman. “As New York’s largest healthcare provider, Northwell Health serves a remarkably diverse patient population. This agreement will provide patient communities with greater access to cutting-edge biomedical technology, allowing for more precise diagnoses and treatments, and ultimately facilitating new breakthroughs in cancer care.”

Hackensack Meridian Neuroscience Institute at JFK University Medical Center Receives $2.2 Million Research Grant to Study A Novel Traumatic Brain Injury Treatment

The NIH grant will fund a project entitled “Neutrophil Extracellular Traps And Associated Pathogenesis In TBI: A Novel Peptide Therapeutic Strategy” proposed by Mohammed Abdul Muneer, MSc, PhD, Research Scientist & Principal Investigator, Hackensack Meridian Neuroscience Institute at JFK University Medical Center, and Associate Professor of Neurology at the Hackensack Meridian School of Medicine.

By using this website you agree to accept Medical Device News Magazine Privacy Policy